Pharmaceutical/Medical Devices

Industry Overview

Oliver Wight provides business process improvement solutions to leading organizations across a range of industries, including consumer packaged goods, industrial manufacturing, pharmaceuticals, chemicals, and retail. Whether your organization operates from a single site or spans a multi-site global network, our team develops customized programs with our exclusive Proven Path methodology tailored for success. Our approach empowers you to enhance operational performance within your organization and throughout the broader supply chain.

About Pharmaceutical/Medical Devices

Pharmaceutical and medical device companies face mounting pressure from volatile supply chains, stricter regulations, and rising financial demands. With global instability, lingering pandemic effects, and uncertainty, uncertainty has become the norm. Success now requires disciplined, integrated planning. Integrated Business Planning (IBP) delivers a single, trusted plan that aligns strategy, market signals, and financial priorities—enabling leaders to make confident decisions, allocate resources effectively, and accelerate results.

Flexibility, Agility, and Efficiency
In today’s pharmaceutical and medical device landscape, flexibility, agility, and efficiency aren’t optional—they’re the difference between success and failure. With countless variables as new drugs move through regulatory approval, the key is to plan predictable pipelines and take control of the future.

Pharmaceutical and medical device manufacturers are navigating increasing complexity—marked by unpredictable supply chains, shifting global regulations, and intense financial pressures. Traditional planning methods can’t keep pace. Integrated Business Planning (IBP) provides a unified, strategic approach that connects commercial, operational, and financial plans, enabling agility and resilience in an unpredictable market.

Top 3 Challenges that Pharma/Medical Device Manufacturers Face and How IBP Solves Them

CHALLENGE 1

Supply Chain Disruption & Volatility

Global shortages, long lead times, and unpredictable demand create costly inventory imbalances.

IBP Solution:

Real-time visibility and scenario modeling to mitigate risk and optimize inventory.

CHALLENGE 2

Regulatory & Quality Complexity

Constantly evolving compliance requirements strain operations and collaboration.

IBP Solution:

Centralized governance and proactive scenario planning for regulatory changes.

CHALLENGE 3

Demand Volatility & Financial Pressure

Uncertain demand and rising costs challenge forecast accuracy and profitability.

IBP Solution:

Synchronize operational and financial plans, improve forecast accuracy, and support ROI-driven decisions.

Why Integrated Business Planning (IBP)?

Integrated Business Planning (IBP) gives drug and device makers the strategic line of sight they need across a 36-month rolling horizon—from the clinical pipeline and transfer through launch and lifecycle management. With a single trusted plan, Leaders can ensure the most important medicines and devices receive the resources they need—such as ingredients, production space, and funding—so patients and healthcare providers are well served, and the business remains healthy.

Learn More

Proven Expertise

We’ve partnered with some of the world’s leading pharmaceutical and medical device companies, including Roche, Genentech, Stryker, Mead Johnson, Bristol-Meyers Squibb, Johnson & Johnson, Abbott, Pfizer, Baxter, Bayer, BD, Lilly, Zimmer Biomet, Hologic, and others, to transform their planning processes. Through Integrated Business Planning (IBP), these organizations have gained the ability to plan with confidence, tackle complexity, and respond proactively to change. Check out our Pharmaceutical/Medical Device Client Benefit Brochure.